Proov, the first & only FDA-cleared at-home ovulation test - Episode 151

Amy Beckley - PhD scientist with a background in hormone signaling. My personal battle with hormone imbalance leading to infertility and recurrent miscarriage led me to invent Proov, the first and only FDA cleared test to help determine ovulation quality. High quality ovulation leads to more pregnancies and better hormone balance in women, so they can live their best lives.

FemTech Focus is a 501c3 non-profit organization founded to empower, equip, and bring together healthcare professionals, life-science entrepreneurs, and forward-thinking investors to revolutionize women’s health and wellness. FemTech Focus elevates the FemTech industry through increased awareness, providing resources to FemTech founders, & creating opportunities to support FemTech startups through exposure, networking, and access to capital.

The FemTech Focus Podcast with Dr. Brittany Barreto is a meaningfully provocative conversational series that brings femtech experts – including doctors, scientists, inventors, and founders – on air to talk about the innovative technology, services, and products (collectively known as femtech) that are improving women’s health and wellness. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.

Dr. Brittany Barreto is a scientist, serial entrepreneur, and venture capitalist. While finishing her PhD in Molecular and Human Genetics at Baylor College of Medicine, Brittany founded Pheramor, the first nationwide DNA-based dating app. She then embarked into venture capital as the Senior Venture Associate at Capital Factory and was tasked with launching the fund’s Houston branch. Brittany now has her sights on advancing women’s health. She is host of the FemTech Focus podcast which has 150+ episodes and 30 thousand downloads in 105 countries. Brittany is the co-founding partner of Coyote Ventures, a US-based venture fund investing in early-stage women’s health startups.